Flourish Research (NMS Capital) Recapitalizes Keystone Clinical Studies
October 6, 2022
Flourish Research, a portfolio company of NMS Capital, partnered with Keystone Clinical Studies' management in a recapitalization transaction. Keystone, a Plymouth Meeting, Pennsylvania-based clinical research site focused on Alzheimer’s disease and CNS conditions, will continue to be led by founder Dr. Cherian Verghese as part of the Flourish platform to expand CNS capabilities and enter the Philadelphia market.
- Buyers
- Flourish Research, NMS Capital
- Targets
- Keystone Clinical Studies, LLC
- Platforms
- Flourish Research
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Recapitalization
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.